Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Participate in Upcoming Conferences
- Corporate and Finance
Nov 25, 2020
Novavax to Host Conference Call for Questions Related to Third Quarter Financial and Operating Results on November 10, 2020
- Corporate and Finance
Nov 10, 2020
Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
- COVID-19
Nov 9, 2020
Novavax Appoints Gregory F. Covino as Chief Financial Officer and Announces Leadership Updates
- Corporate and Finance
Nov 9, 2020
Novavax Reports Third Quarter 2020 Financial and Operational Results
- Corporate and Finance
Nov 9, 2020
Novavax and Commonwealth of Australia Announce Agreement in Principle for Acquisition of Novavax COVID-19 Vaccine
- COVID-19
Nov 4, 2020
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
- Corporate and Finance
Nov 3, 2020
Novavax Appoints Biopharmaceutical Industry Veteran Gregg Alton to Board of Directors
- Corporate and Finance
Nov 3, 2020
Novavax Announces Facility Expansion to Support Global Vaccine Development
- COVID-19
Nov 2, 2020
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
- COVID-19
Oct 27, 2020
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020
- COVID-19
Oct 20, 2020
Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure
- Seasonal Influenza
Oct 13, 2020
Novavax to Participate in Upcoming Conferences
- Corporate and Finance
Oct 5, 2020
Novavax to Present COVID-19, Influenza and RSV Candidate Vaccine Data at World Vaccine Congress Washington 2020
- COVID-19
Sep 28, 2020
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
- COVID-19
Sep 24, 2020
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Production Capacity to Over 2 Billion Doses Annually
- COVID-19
Sep 15, 2020
Novavax to Participate in Upcoming Investor Conferences
- Corporate and Finance
Sep 10, 2020
Biopharma Leaders Unite to Stand with Science
- Partners
Sep 8, 2020
Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
- COVID-19
Sep 2, 2020
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
- COVID-19
Aug 31, 2020
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
- COVID-19
Aug 24, 2020
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
- COVID-19
Aug 17, 2020
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate
- COVID-19
Aug 14, 2020
Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate
- COVID-19
Aug 13, 2020
Novavax Reports Second Quarter 2020 Financial and Operational Results
- Corporate and Finance
Aug 10, 2020

Show per page